Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study
Grazia Anna Niro(Casa Sollievo della Sofferenza), Mario Rizzetto(University of Turin), Antonina Smedile(Ospedale Papa Giovanni XXIII), Antonella Olivero(University of Turin), Rosanna Fontana(Casa Sollievo della Sofferenza), Hans L. Tillman(Duke University), M. Lagget(Fondazione Ricerca Molinette), Nancy Little(Research Triangle Park Foundation), Alessia Ciancio(Department of Medical Sciences), Francesco Perri(Casa Sollievo della Sofferenza), Michael P. Manns(Medizinische Hochschule Hannover), Fiona Campbell(University of Birmingham), Angelo Andriulli(Casa Sollievo della Sofferenza)
Cited by 113
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
|Hepatology|2003|2.7k
What is meant by intention to treat analysis? Survey of published randomised controlled trials
|BMJ|1999|2.2k
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
|The Lancet. Gastroenterology & hepatology|2016|2k
Effectiveness of brief alcohol interventions in primary care populations
|Cochrane Database of Systematic Reviews|2018|1.7k